Compounding Pharmacy · Houston, TX · 503A

iPharma Pharmacy Review

iPharma Pharmacy is a licensed 503A compounding pharmacy in Houston, TX (5400 Katy Fwy) with a sterile-compounding lab and certified clean rooms. It compounds across many areas, including HRT, dermatology, dental, veterinary, and weight loss. Through its online telehealth storefront it now sells compounded tirzepatide/glycine injectables starting at $249 and semaglutide/glycine injectables starting at $165, and it still markets its in-house 'iSlimWell' formula. It says it is licensed to serve patients in 21 states, with sterile compounding licenses in TX, AZ, and NY.

iPharma sells semaglutide and tirzepatide blended with glycine through its own online storefront instead of only through outside telehealth brands, so compounded semaglutide's FDA status applies directly to what it markets. It holds sterile compounding licenses in Texas, Arizona and New York while serving 21 states, so check state-level compounding rules for yours.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

503AState pharmacy licenseUSP 797 sterile compounding
Location: Houston, TX
States licensed: 5
5.0/10
★★★☆☆2.5/5

Editorial score out of 10 · methodology

Top-Rated GLP-1 Partners

Not sourced from iPharma Pharmacy — these are our highest-scored vetted GLP-1 telehealth partners, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

No insurance needed · HSA/FSA eligible · vetted by our editors

7.7

Ro

FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

Starting price: $149/mo (+ required membership)

Get started →Read review Ro →
8.3

Collective

The lowest flat medication price if you can absorb an annual membership fee

Starting price: $59/mo (+ required membership)

Get started →Read review Collective →
8.3

CoreAge Rx

Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

Starting price: $79/mo (“starting at” price)

Get started →Read review CoreAge Rx →
7.8

Embody

Low flat-rate compounded GLP-1 pricing at every dose

Starting price: $79/mo (sale price)

Get started →Read review Embody →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

State pharmacy license
Licensed by the pharmacy's home state board of pharmacy. All US pharmacies must hold a state license at minimum.
503A
Traditional patient-specific compounding pharmacy under Section 503A — compounds individual prescriptions and is regulated primarily by its state board of pharmacy.
USP 797 sterile compounding
United States Pharmacopeia compounding standards (USP <795> non-sterile, <797> sterile, <800> hazardous drugs) — the quality chapters state boards enforce for compounded preparations.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed (5)

TXAZILFLNY

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for iPharma Pharmacy. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing9/10
State Coverage1/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Pharmacy details last verified November 2026 · How we verify provider data

Frequently Asked Questions

iPharma Pharmacy is a 503A compounding pharmacy based in Houston, TX. It operates under state board of pharmacy licensure. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
iPharma Pharmacy is headquartered in Houston, TX. The pharmacy is licensed to ship to 5 US states.
iPharma Pharmacy produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology (as of November 2026)
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.